Evaluation of the prescriptions of medicines to subjects with Diabetes Mellitus assisted by a Basic Unit of Health;Avaliação de prescrições de medicamentos para pacientes com Diabetes Mellitus atendidos por uma Unidade Básica de Saúde

Revista de Ciencias Farmaceuticas Basica e Aplicada

Volumn 26, Issue 3, 2005, Pages 199-203

  Pereira, Leonardo R L ^a   Andrade, R C G ^a,c   Pereira, J G C ^b   Marchetti, J M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Secretaria Municipal da Saúde de Ribeirão Preto   (Brazil)

^c UNIVERSITY OF RIBEIRÃO PRETO   (Brazil)

Author keywords

Diabetes mellitus; Oral antidiabetic drugs; Pharmacoepidemiology

Indexed keywords

GLIBENCLAMIDE; INSULIN; METFORMIN;

ARTICLE; DIET SUPPLEMENTATION; DYSLIPIDEMIA; FOLLOW UP; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MONOTHERAPY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRESCRIPTION; RISK FACTOR; WORLD HEALTH ORGANIZATION;

EID: 33845545427     PISSN: 18084532     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Alberti KGMM, Zimmet PZ. WHO Consultation. Definition, diagnosis and classification of diabetes mellitus and its complications, Part 1: Diagnosis and classification of diabetes mellitus, provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
2. American Diabetes Association. Clinical Practice Recommendations: Diabetic Nephropathy. Diabetes Care 1999;22(Suppl 1):S66-9.
3. Coutinho WF. Consenso Latino-Americano de Obesidade: até onde já chegamos. Arq Bras Endocrinol Metab 1999;43:21-67.
4. Decode Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999;354:617-21.
5. Guidelines Subcommittee of the WHO. World Health Organization International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999;17:151-83.
6. Holman RR, Cull CA, Turner RC. A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44). Diabetes Care 1999;22:960-4.
7. Koskinen P, Mänttäri M, Manninen V, Huttunen JK, Heinonen OP, Frick MH. Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 1992;15:820-5.
8. Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, Yale JF, Zinman B, Lillie D. Clinical practice guidelines for the management of diabetes in Canada. Can Med Assoc J 1998;159(Suppl):S1-29.
9. Muls E. Nutrition recommendations for the person with diabetes. Clin Nutr 1998;17(Suppl 2):18-25.
10. Panzram G. Mortality and survival in Type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1987;30:123-31.
11. Reichelt AJ, Spichler ER, Branchtein L, Nucci LB, Franco LJ, Schmidt MI. Fasting plasma glucose is a useful test for the detection of gestational diabetes. Diabetes Care 1998;21:1246-9.
12. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183.
13. The Sixth Report of the Joint National Committee on Detection. Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-45.
14. UK Prospective Diabetes Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes: UKPDS 34. Lancet 1998a;352:854-65.
15. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes: UKPDS 33. Lancet 1998b;352:837-53.
16. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998c;317:703-12.
17. Willianson DF, Pamuk E, Thun M. Prospective study of intentional weight loss and mortality in never-smoking overweight US white women aged 40-64 years. Am J Epidemiol 1995;141:1128-41.
18. Yki-Järvinen H, Ryysy L, Nikkilä K, Tulokas T, Vanamo R, Heikkilä M. Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. Ann Intern Med 1999;130:389-96.